Skip to main content
Clinical Trials/KCT0005227
KCT0005227
Withdrawn
未知

Bronchial artery Embolization for Non-massive and Clinically-stable Hemoptysis patients (BENCH): Randomized Controlled Trial

Seoul National University Hospital0 sites116 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Seoul National University Hospital
Enrollment
116
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • a. Age \>\= 19
  • b. hemoptysis amount \=\< 200cc/24hr
  • c. Stable vital sign
  • \- heart rate \< 100 beats/min
  • \- Systolic blood pressure \> 90 mmHg
  • \- Respiratory rate \< 24 breaths/min
  • \- SpO2 \> 90%
  • d. No history of intervention or surgery within 3 years to control hemoptysis
  • e. bronchial artery hypertrophy on CT
  • f. Benign lung parenchymal disease (e.g., tuberculosis, bronchiectasis) on CT

Exclusion Criteria

  • a.Patients with anticoagulation / antiplatelet agents
  • b.Coagulopathy (INR\>1\.5\) or thrombocytopenia (Platelet count \<50K)
  • c.Pregnant or lactating women
  • d.Malignant neoplasms in the lung and bronchus
  • e.Traumatic hemoptysis
  • f.Iatrogenic hemoptysis
  • g.Pulmonary artery thromboembolism
  • h.Vasculitis
  • i.Contraindication to tranexamic acid

Outcomes

Primary Outcomes

Not specified

Similar Trials